Bath & Body Works, Inc. $BBWI Stock Holdings Increased by Strs Ohio

Key Points

• Strs Ohio boosted its position in Bath & Body Works by 8,777.2% in Q4, buying 446,845 shares to hold 451,936 shares (about 0.22% of the company) worth $9,075,000, while overall institutional ownership stands at 95.14% and several other large funds (RBC, Goldman, UBS) also increased stakes.
• Bath & Body Works beat Q results (EPS $2.05 vs. $1.77 est.; revenue $2.72B vs. $2.59B), set FY26 guidance of $2.40–$2.65 EPS, and is trading around $18.58 with a PE of 5.9—the consensus analyst rating is Hold with an average price target of $23.00.

Strs Ohio boosted its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 8,777.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 451,936 shares of the company's stock after buying an additional 446,845 shares during the quarter. Strs Ohio owned approximately 0.22% of Bath & Body Works worth $9,075,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Royal Bank of Canada boosted its stake in Bath & Body Works by 92.8% in the first quarter. Royal Bank of Canada now owns 59,877 shares of the company's stock valued at $1,815,000 after acquiring an additional 28,815 shares during the period. Goldman Sachs Group Inc. boosted its stake in Bath & Body Works by 15.7% in the first quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company's stock valued at $19,586,000 after acquiring an additional 87,529 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Bath & Body Works by 7.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company's stock valued at $17,063,000 after acquiring an additional 36,684 shares during the period. Intech Investment Management LLC acquired a new position in Bath & Body Works in the first quarter valued at approximately $1,155,000. Finally, Geneos Wealth Management Inc. boosted its stake in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock valued at $35,000 after acquiring an additional 801 shares during the period. 95.14% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have commented on BBWI shares. Citigroup downgraded Bath & Body Works from a "buy" rating to a "neutral" rating and lifted their target price for the company from $21.00 to $25.00 in a research note on Tuesday, February 17th. Deutsche Bank Aktiengesellschaft lifted their target price on Bath & Body Works from $21.00 to $22.00 and gave the company a "hold" rating in a research note on Tuesday, March 3rd. Barclays lifted their target price on Bath & Body Works from $20.00 to $21.00 and gave the company an "equal weight" rating in a research note on Monday, March 2nd. UBS Group lifted their target price on Bath & Body Works from $21.00 to $22.00 and gave the company a "neutral" rating in a research note on Monday, February 23rd. Finally, Zacks Research upgraded Bath & Body Works from a "strong sell" rating to a "hold" rating in a research note on Tuesday, January 20th. Three analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $23.00.

Bath & Body Works Trading Down 3.3%

Shares of NYSE BBWI opened at $18.58 on Tuesday. The stock has a 50 day simple moving average of $19.89 and a 200-day simple moving average of $21.10. The company has a market cap of $3.74 billion, a PE ratio of 5.90, a P/E/G ratio of 1.92 and a beta of 1.43. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $34.66.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Wednesday, March 4th. The company reported $2.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.77 by $0.28. The business had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.59 billion. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The business's revenue was down 2.3% on a year-over-year basis. During the same period in the previous year, the firm posted $2.09 earnings per share. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Sell-side analysts forecast that Bath & Body Works, Inc. will post 2.6 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 6th. Stockholders of record on Friday, February 20th were given a dividend of $0.20 per share. The ex-dividend date was Friday, February 20th. This represents a $0.80 annualized dividend and a dividend yield of 4.3%. Bath & Body Works's payout ratio is currently 25.40%.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.